Softgel Capsule Market, By Product Type (Gelatin Softgel Capsule, Non-gelatin Softgel Capsule), By Source Type (Animal-based, Non-animal-based), By Application (Anti-inflammatory Drugs, Antibiotic Drugs, Cardiovascular Drugs, Health Supplements, Others), By End User (Pharmaceutical Companies, Contract Manufacturing Organizations, Neutraceuticals Companies, Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Published In : Dec 2023

Code : CMI4265

Pages :172

Formats :

Excel and PDF

Industry : Pharmaceutical

Regional Analysis

Global Softgel Capsule Market- Regional Insights

North America is expected to be the largest market for softgel capsule during the forecast period, accounting for over 35.7% of the market share in 2023. North America has established itself as the dominant regional market for softgel capsule. This is due to strong healthcare infrastructure and expenditure in countries like the U.S. along with the widespread presence of major capsule manufacturers operating production facilities in the region. These companies have been investing heavily in research and development (R&D) to develop innovative softgel dosage formulations, targeting different therapeutic applications. As a result, the region enjoys early adoption of new softgel products and holds a leading share of patent filings. While the presence of mature markets, regulations, and population demographics make growth slower, relative to other regions, continuous innovation ensures constant demand from pharmaceutical and nutraceutical end users. The region also dominates capsule exports globally, leveraging trade agreements. Overall stability, opportunities for new product launches, and a favorable regulatory environment have allowed North America to sustain its primacy in this marketplace
Asia Pacific market is expected to be the second-largest market for softgel capsule market, accounting for over 25.2% of the market share in 2023. The Asia Pacific region has emerged as the fastest expanding softgel capsule market globally. Countries like China, India, Japan and South Korea have growing healthcare needs of their large and rapidly developing populations. This burgeoning demand is complemented by increased per capita incomes and rising health awareness., Favorable policies to promote the domestic manufacturing of pharmaceuticals have attracted major global softgel capsule companies to set up production bases in the region to cater to local as well as international sales. Coupled with lower costs of production, these factors are powering the Asia Pacific market ahead of others. Further aiding growth is its position as the largest producer and consumer of herbs and botanical extracts that find widespread application in softgel supplements. Overall, Asia Pacific seems well-placed to continue its momentum as the most swiftly increasing regional market for softgel capsules.
Europe market is expected to be the fastest-growing market for softgel capsule market, with a share of 19% during the forecast period. The growth of the market in Europe is due to the increasing prevalence of coronary artery disease in the region.

Figure 1. Global Softgel Capsule Market Share (%), By Region, 2023